Anke Gradehandt

  • Citations Per Year
Learn More
BACKGROUND Loss of disialoganglioside 2 (GD2) expression in neuroblastoma (NB) bone marrow cells has been reported in rare cases. This study investigated prospectively the frequency and the patterns of visible GD2 loss at diagnosis, during treatment, and at recurrence. METHODS Bone marrow aspirates of patients with new or recurrent stage 4 and 4S NB(More)
  • 1